Welcome to Ligand Pharmaceuticals

Ligand is a high-growth company with economic rights to some of the world's most important medicines.

Portfolio
Technologies
Licensing Opportunities

Investor Relations

View Investor Relations

Latest News

Ligand Prices Offering of $650 Million of Convertible Senior Notes

Read More

Ligand Announces Proposed Offering of $650 Million of Convertible Senior Notes

Read More

Ligand to Participate in Upcoming Investor Conferences

Read More

Recent Events

Stock Snapshot

LGND
Nasdaq
Volume
Market Cap
Day Range
52-Week Range